DKZ: Enzyme Immunoassay, Amphetamine
What it covers
An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.
The identification in 21 CFR 862.3100, amphetamine test system. FDA gives DKZ no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K240670 | DRI Ecstasy Plus Assay | Microgenics Corporation | Oct 30, 2024 | Special |
| K233019 | AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Rapid Test Panel; AllTest Multi-Drug Rapid Test Cup Rx; AllTest Multi-Drug Rapid Test Panel Rx | Hangzhou AllTest Biotech Co., Ltd. | Dec 13, 2023 | Traditional |
| K231137 | Xenta Drug Screen Cup, Xenta Drug Screen Dipcard | Xenta Biomedical Science Co., Ltd. | May 19, 2023 | Traditional |
| K200363 | Quidel Triage® TOX Drug Screen, 94600 | Quidel Cardiovascular, Inc. | Mar 11, 2020 | Special |
| K191099 | Atlas Multi-Drugs Screening Test Cup, Atlas Multi-Drugs Screening Test Panel | Atlas Medical | Oct 3, 2019 | Traditional |
| K182719 | Quidel Triage TOX Drug Screen, 94600; Quidel Triage® MeterPro | Quidel Cardiovascular, Inc. | Jun 19, 2019 | Traditional |
| K182738 | Single and Multi-Drug Rapid Test Panel With Adulteration (Urine), Single and Multi-Drug Rapid Test Panel (Urine), Single and Multi-Drug Rapid Test Cup With Adulteration (Urine), Single and Multi-Drug Rapid Test Cup (Urine), Single Drug Rapid Test Dipstick (Urine), Single and Multi-Drug Home Rapid Test Panel (Urine), Single and Multi-Drug Home Rapid Test Cup (Urine), Single Drug Home Rapid Test Dipstick (Urine) | Hangzhou AllTest Biotech Co., Ltd. | Mar 27, 2019 | Traditional |
| K180879 | BIO-VENTURE Rapid Multi-Drug Test Easy Cup for OTC Use, BIO-VENTURE Rapid Multi-Drug Test Split Key Cup for OTC Use, BIO-VENTURE Rapid Multi-Drug Test Easy Cup for Rx Use, BIO-VENTURE Rapid Multi-Drug Test Split Key Cup for Rx Use | Shanghai Venture Bio-Tech Co., Ltd. | Dec 14, 2018 | Traditional |
| K181945 | QuickScreen Pro Multi Drug Screening Test, Model 9395Z | Phamatech, Inc. | Oct 18, 2018 | Traditional |
| K173303 | INSTANT-VIEW plus Multi-Drug of Abuse Urine Test - Simple Cup (OTC Use), INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use) | Alfa Scientific Designs, Inc. | Feb 23, 2018 | Traditional |
Clearances by year
47 DKZ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2024 | 1 | 233 |
| 2023 | 2 | 55 |
| 2020 | 1 | 26 |
| 2019 | 3 | 180 |
| 2018 | 3 | 128 |
| 2016 | 5 | 215 |
| 2015 | 5 | 107 |
| 2014 | 8 | 128 |
| 2013 | 8 | 103 |
| 2012 | 5 | 55 |
| 2011 | 6 | 123 |
Who submits
28 applicants cleared a DKZ device since 2011. 79% of the clearances went to applicants in United States, then China (17%), United Kingdom (2%) and Jordan (2%). By type: Traditional 79%, Special 19% and Abbreviated 2%.
| Applicant | Clearances since 2011 |
|---|---|
| Ucp Biosciences, Inc. | 7 |
| Guangzhou Wondfo Biotech Co., Ltd. | 6 |
| Alfa Scientific Designs, Inc. | 3 |
| Chemtron Biotech, Inc. | 3 |
| Co-Innovation Biotech Co., Ltd. | 2 |
| Hangzhou AllTest Biotech Co., Ltd. | 2 |
| Phamatech, Inc. | 2 |
| Quidel Cardiovascular, Inc. | 2 |
How FDA classifies it
Class II (special controls). An amphetamine test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.
From 21 CFR 862.3100. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 862.3100 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DKZ clearances declared.
Ask about DKZ
Questions about DKZ
What is FDA product code DKZ?
Product code DKZ, “Enzyme Immunoassay, Amphetamine” in FDA's classification database, is a Class II device type under 21 CFR 862.3100 (amphetamine test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 225 clearances under DKZ, 47 of them since 2011.
How many 510(k) clearances are there under DKZ?
FDA’s 510(k) database listed 225 clearances under DKZ as of Oct 29, 2026, 47 of them decided since 2011; the most recent decision was Oct 30, 2024. The Predicate Finder searches the live database.
How long does FDA take to clear a DKZ 510(k)?
For the 1 DKZ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 233 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DKZ clearances?
Since 2011: Ucp Biosciences, Inc. (7), Guangzhou Wondfo Biotech Co., Ltd. (6), Alfa Scientific Designs, Inc. (3), Chemtron Biotech, Inc. (3) and Co-Innovation Biotech Co., Ltd. (2). 28 applicants have cleared a DKZ device in that time.